Effect of Xuebijing injection on renal high mobility group box-1 protein expression and acute kidney injury in rats scald injury

Acta Academiae Medicinae Sinicae

Volumn 29, Issue 4, 2007, Pages 478-483

  Wang, Qiang ^a,b   Yao, Yong Ming ^a   Wang, Wen Jiang ^a   Xian, Li Ming ^a   Dong, Ning ^a   Xu, Shan ^a   Dou, Ke Feng ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; High mobility group box 1 protein; Scald injury; Xuebijing injection

Indexed keywords

CHINESE DRUG; CREATININE; EOSIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMATOXYLIN; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; XUEBIJING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY INJURY; KIDNEY PARENCHYMA; MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; RAT; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCALD; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; BURNS; DRUGS, CHINESE HERBAL; HMGB1 PROTEIN; INJECTIONS; KIDNEY; KIDNEY FAILURE, ACUTE; RATS; RATS, WISTAR;

EID: 34648820078     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, Northern Ireland [J]. Crit Care Med, 2003, 31 (9): 2332-2338.
2. Schrier RW, Wang W. Mechanisms of disease: acute renal failure and sepsis [J]. New Engl J Med, 2004, 351 (2): 159-169.
3. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice [J]. Science, 1999, 285 (5425): 248-251.
4. Yang H, Wang H, Czura CJ, et al. The cytokine activity of HMGB1 [J]. J Leukoc Biol, 2005, 78(1): 1-8.
5. Chinese source.
6. Mantell LL, Parrish WR, Ulloa L. HMGB-1 as a therapeutic target for infectious and inflammatory disorders [J]. Shock, 2006, 25 (1): 4-11.
7. Chinese source.
8. Chinese source.
9. Chinese source.
10. Chinese source.
11. Chinese source.
12. Chinese source.
13. Chinese source.
14. Chinese source.